NDC properties for "TOBI Podhaler Weekly Kit, 56" (RxCUI 1661560)
About this data
The tables show NDC propoerties for TOBI Podhaler Weekly Kit, 56 with the RxCUI 1661560
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for TOBI Podhaler Weekly Kit, 56 (RxCUI 1661560)
| NDA | NDA201688 |
|---|---|
| RxCUI | 1661560 |
| SPL_SET_ID | c4b5bb1f-e158-4ac1-9c35-e98a416c743a |
| Prescribable Synonym | TOBI Podhaler 56 Capsule Weekly Pack |
| RXNAV_STR | TOBI Podhaler Weekly Kit, 56 |
| RxNorm Name | {56 (tobramycin 28 MG Inhalation Powder [Tobi]) } Pack [TOBI Podhaler Weekly Kit] |
| RxNorm Synonym | TOBI Podhaler Weekly Kit, 56 |
| RxNorm Synonym | TOBI Podhaler Weekly Kit, including 56 capsules (7 Blister Cards of 8 Capsules) |
| Related queries | Interactions (for RxCUI 1661560) |
NDC Properties
NDC Item 00078063056
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-56 |
| NDC Item | 00078063056 |
| Packaging | 56 in 1 PACKAGE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 511513 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 49502034656
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-56 |
| NDC Item | 49502034656 |
| Packaging | 56 CAPSULE in 1 BOX, UNIT-DOSE (49502-346-56) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 681698 |
| Imprint code | NVR;AVCI |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2023-05-31 |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502040156
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-56 |
| NDC Item | 49502040156 |
| Packaging | 56 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-56) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 49502040157
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-57 |
| NDC Item | 49502040157 |
| Packaging | 7 BLISTER PACK in 1 BOX, UNIT-DOSE (49502-401-57) / 8 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 00078063056
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-56 |
| NDC Item | 00078063056 |
| Packaging | 56 in 1 PACKAGE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 511513 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 49502034656
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-56 |
| NDC Item | 49502034656 |
| Packaging | 56 CAPSULE in 1 BOX, UNIT-DOSE (49502-346-56) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 681698 |
| Imprint code | NVR;AVCI |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2023-05-31 |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502040156
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-56 |
| NDC Item | 49502040156 |
| Packaging | 56 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-56) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 49502040157
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-57 |
| NDC Item | 49502040157 |
| Packaging | 7 BLISTER PACK in 1 BOX, UNIT-DOSE (49502-401-57) / 8 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 00078063056
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-56 |
| NDC Item | 00078063056 |
| Packaging | 56 in 1 PACKAGE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 511513 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 49502034656
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-56 |
| NDC Item | 49502034656 |
| Packaging | 56 CAPSULE in 1 BOX, UNIT-DOSE (49502-346-56) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 681698 |
| Imprint code | NVR;AVCI |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2023-05-31 |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502040156
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-56 |
| NDC Item | 49502040156 |
| Packaging | 56 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-56) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 49502040157
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-57 |
| NDC Item | 49502040157 |
| Packaging | 7 BLISTER PACK in 1 BOX, UNIT-DOSE (49502-401-57) / 8 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 00078063056
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-56 |
| NDC Item | 00078063056 |
| Packaging | 56 in 1 PACKAGE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 511513 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2022-07-31 |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 49502034656
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-56 |
| NDC Item | 49502034656 |
| Packaging | 56 CAPSULE in 1 BOX, UNIT-DOSE (49502-346-56) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 681698 |
| Imprint code | NVR;AVCI |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2023-05-31 |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502040156
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-56 |
| NDC Item | 49502040156 |
| Packaging | 56 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-56) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 49502040157
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-57 |
| NDC Item | 49502040157 |
| Packaging | 7 BLISTER PACK in 1 BOX, UNIT-DOSE (49502-401-57) / 8 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |